|
|
 | | | |
- close
- close
- close
- close
QUOTE AND NEWS
Benzinga
Apr 10
Comment
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
PR Newswire
Apr 10
Comment
MEMPHIS, Tenn., April 10, 2012 /PRNewswire/ -- On March 31st, Motown Legends The Temptations Review featuring Dennis Edwards, The Four Tops, Marilyn McCoo and Billy Davis Jr., and Thelma Houston performed before a capacity crowd of nearly 800 at the
Benzinga
Mar 14
Comment
Auriga reduces its price target $5 to $21 on Buy-rated Medifast (NYSE: MED) on persisting growing pains.
Auriga says, "Medifast announced 4Q11 results and 1Q12 guidance that was below our expectations, partially due to margin pressure...
Benzinga
Mar 13
Comment
Shares of Medifast (NYSE: MED) are trading lower in the after-hours following the release of the company's Q4 earnings results. Currently, shares are bid $15.16, at $15.44; they ended the regular session higher by 4.31%, at $16.70.
Medifast...
PR Newswire
Feb 15
Comment
OWINGS MILLS, Md., Feb. 15, 2012 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven portion-controlled weight-loss programs, will announce financial results for the fourth quarter and
StreetInsider.com
Feb 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Medifast+%28MED%29+Appoints+Michael+McDonald+as+CEO/7132469.html for the full story.
PR Newswire
Feb 2
Comment
OWINGS MILLS, Md., Feb. 2, 2012 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven portion-controlled weight-loss programs, today announced that the Company's Board of Directors has
Reuters
Dec 12
Comment
Iran raised its January official selling price (OSPs) to Northwest Europe and the Mediterranean moderately while hiking the price to Asia to record highs on Monday, as the EU works on a potential embargo on Iranian crude.
Marketwire
Nov 22
Comment
NEW YORK, NY -- (Marketwire) -- 11/22/11 -- Today, www.BollingerReport.com introduced featured coverage of Medifast, Inc. (NYSE: MED) and Ultrapar Participacoes SA (ADR) (NYSE: UGP). Full research reports are available to readers at:
Benzinga
Nov 4
Comment
Shares of Medifast (NYSE: MED) are lower on the session by 3.58%, currently trading at $14.80. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average.
Options traders are...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
